Terms ending in 2028
Every in-force patent on Actelion Pharmaceuticals Ltd's record whose computed term ends in 2028, whoever holds it now. Soonest term end first, then patent number.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Holder | Status | Expires | Confidence |
|---|---|---|---|---|---|
| US 8,044,055 | 2-Phenyl-6-Aminocarbonyl-PYRIMIDINE Derivatives and Their Use as P2Y12 Receptor In force · Medium confidence | Viatris Asia Pacific Pte. Ltd. | In force | Medium confidence | |
| US 7,868,012 | Sulfamides as Endothelin Receptor Antagonists for the Treatment of Cardiovascular Diseases In force · High confidence | Actelion Pharmaceuticals, Ltd. | In force | High confidence | |
| US 8,221,978 | Normalization Probes for Comparative Genome Hybridization Arrays In force · High confidence | Agilent Technologies, Inc. | In force | High confidence | |
| US 8,093,250 | 2-Aminocarbonyl-PYRIDINE Derivatives In force · High confidence | Viatris Asia Pacific Pte. Ltd. | In force | High confidence | |
| US 8,263,780 | New Process for the Preparation of 2-Imino-THIAZOLIDIN-4-ONE Derivatives In force · High confidence | Vanda Pharmaceuticals Inc. | In force | High confidence | |
| US 8,912,340 | New Process for the Preparation of 2-Imino-THIAZOLIDIN-4-ONE Derivatives In force · High confidence | Vanda Pharmaceuticals Inc. | In force | High confidence | |
| US 8,124,623 | 5-Hydroxymethyl-OXAZOLIDIN-2-ONE-DERIVATIVES and Their Uses as Antibacterials In force · High confidence | Actelion Pharmaceuticals Ltd. | In force | High confidence | |
| US 8,367,685 | Stable Pharmaceutical Compositions Comprising a Pyrimidine-Sulfamide In force · High confidence | Actelion Pharmaceuticals Ltd. | In force | High confidence |
8 of 8 patents shown. Soonest term end first, then patent number.
3 of these are in force and held by Actelion Pharmaceuticals Ltd.
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.